Processa Pharmaceuticals, Inc.

Ownership Transactions Reported by 14 Insiders

Symbol
PCSA on Nasdaq
Industry
Pharmaceutical Preparations
Location
7380 Coca Cola Drive, Suite 106, Hanover, MD

Insiders trading volume in the past year

Processa Pharmaceuticals, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Michael Floyd Chief Operating Officer $1.13M Feb 9, 2023
David Young Pres. Research & Development, Director $101K Oct 1, 2025
James H. Stanker Chief Financial Officer $61.6K Apr 5, 2024
Patrick Lin Chief Business - Strategy Off $59.9K +$34.7K +138% Oct 1, 2025
Khalid Islam Director $58K Mar 31, 2022
Sian Bigora Chief Development Officer $56.3K Oct 1, 2025
Wendy Guy Chief Administrative Officer $49.9K Oct 1, 2025
Virgil Thompson Director $42.2K Jun 27, 2023
George Ng Chief Executive Officer, Director $31.7K Oct 1, 2025
Justin W. Yorke Director $11.2K +$9.89K +728% Oct 1, 2025
Russell Skibsted Chief Financial Officer $5.88K Oct 1, 2025
James Neal Director Oct 1, 2025
Geraldine Pannu Director Oct 1, 2025
Khoso Baluch Director Oct 1, 2025

Recent Insider Transactions by Companies or Individuals for Processa Pharmaceuticals, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.